Screening method utilizing thalidomidetargeting factor

Details for Australian Patent Application No. 2010309035 (hide)

Owner Tokyo Institute of Technology Fujimoto Pharmaceutical Corporation

Inventors Handa, Hiroshi; Ando, Hideki; Itoh, Takumi; Hotta, Kentaro

Agent FB Rice

Pub. Number AU-A-2010309035

PCT Pub. Number WO2011/049043

Priority 2009-241290 20.10.09 JP

Filing date 18 October 2010

Wipo publication date 28 April 2011

International Classifications

G01N 33/566 (2006.01) Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

G01N 33/15 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Medicinal preparations

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

Event Publications

12 April 2012 PCT application entered the National Phase

  PCT publication WO2011/049043 Priority application(s): WO2011/049043

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010309050-Water-based paste containing diclofenac sodium

2010309030-Transdermally absorbable donepezilcontaining preparation